Arcutis Clinical Site 22 — New York, New York

Arcutis Clinical Site 22 is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Arcutis Clinical Site 22 has participated in 2 clinical trials.

Therapeutic areas: Plaque Psoriasis.

Sponsors: Arcutis Biotherapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Arcutis Clinical Site 22?

Arcutis Clinical Site 22 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Arcutis Clinical Site 22 conducted?

Arcutis Clinical Site 22 has 2 clinical trials on record. Their work covers Plaque Psoriasis.

Is Arcutis Clinical Site 22 accredited by Crixeo Health?

Arcutis Clinical Site 22 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Arcutis Clinical Site 22?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.